By F. Bandello, M. Battaglia Parodi, A.J. Augustin, P. Iacono, R.O. Schlingemann, U. Schmidt-Erfurth, F.D. Verbraak
The advance of remedy with anti-angiogenics or vascular endothelial progress issue inhibitors (anti-VEGF) has marked the start of a brand new period in neovascularization and macular edema therapy. Its major targets are the inhibition of development and improvement of recent vessels besides the relief of vascular permeability. the benefits over traditional laser photocoagulation are glaring as laser therapy consistently leaves scars and factors a retinal sensitivity deterioration. beginning with an overview of remedy rules, this quantity covers all features of anti-VEGF treatment for ophthalmological problems. specifically, particular chapters are devoted to age-related macular degeneration, degenerative myopia, angioid streaks, inflammatory ailments, hereditary dystrophies, retinal vein occlusion, diabetic retinopathy, ocular tumors, in addition to anterior section neovascularization. The publication supplies an replace at the program of anti-VEGF in ocular illnesses to common ophthalmologists in addition to retina experts.
Read or Download Anti-vegf (Developments in Ophthalmology) PDF
Similar ophthalmology books
ThisВ third Glaucoma quantity of the necessities in Ophthalmology sequence, as within the first and the second one, offers an image of modern development within the box of glaucoma, in either easy medical examine and utilized scientific technology. Its purpose isn't to exchange textbooks on glaucoma, yet to function a conceptual bridge among unique study and textbook presentation.
* this article represents a standard method of the analysis and administration of binocular imaginative and prescient issues * it's a sensible, very sleek textual content with a hugely designed structure and with wide use of complete color illustrations * Containing contributions through correct specialists within the box it truly is carefully edited to make sure that a uniform and continuously excessive average is maintained all through
Surgical Anatomy of the Ocular Adnexa is a superbly and thoughtfully illustrated anatomical textual content that gives the ophthalmic health professional or any medical professional operating within the eyelid/orbital sector with special but concise, effortless to learn and comprehend descriptions of the anatomy in any specific area of the eyelid, orbit or nasolacrimal approach.
An entire replace of a vintage reference through experts on the Mayo sanatorium, Henderson's Orbital Tumors, Fourth variation collates the Clinic's fifty years' adventure in dealing with tumors regarding the orbit. Drawing on case studies and broad follow-up info from over 1,700 sufferers taken care of on the health center, the authors formulate accomplished guidance on analysis and clinical and surgical operation of the full spectrum of orbital tumors.
- Nutrition and the Eye: A Practical Approach
- Multiple Choice Questions in Ophthalmic and Neurophysiology
- Diagnostic Atlas of Veterinary Ophthalmology
- 2007-2008 Basic and Clinical Science Course Section 4: Ophthalmic Pathology and Intraocular Tumors
- The Slit Lamp: Applications for Biomicroscopy and Videography
Additional info for Anti-vegf (Developments in Ophthalmology)
Invest Ophthalmol Vis Sci 2004;45:7– 14. 44 Hasegawa T, McLeod DS, Prow T, Merges C, Grebe R, Lutty GA: Vascular precursors in developing human retina. Invest Ophthalmol Vis Sci 2008;49: 2178–2192. 45 Hughes S, Yang HJ, Chan-Ling T: Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 2000;41: 1217–1228. 46 Gariano RF: Cellular mechanisms in retinal vascular development. Prog Retin Eye Res 2003;22:295– 306. 47 Chan-Ling T, McLeod DS, Hughes S, Baxter L, Chu Y, Hasegawa T, et al: Astrocyte-endothelial cell relationships during human retinal vascular development.
Ophthalmology 2009; 116:2393–2399. 21 Waheed NK, Miller JW: Aptamers, intramers, and vascular endothelial growth factor. Int Ophthalmol Clin 2004;44:11–22. 22 Famulok M, Mayer G, Blind M: Nucleic acid aptamers – from selection in vitro to applications in vivo. Acc Chem Res 2000;33:591–599. 23 Ellington AD, Szostak JW: In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818–822. 24 Schachat AP: New treatments for age-related macular degeneration. Ophthalmology 2005;112:531–532.
Retina 2006;26:383–390. 50 Rich RM, Rosenfeld PJ, Puliafito CA, et al: Shortterm safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina 2006;26:495–511. 51 Avery RL, Pieramici DJ, Rabena MD, et al: Intravitreal bevacizumab (Avastin) for neovascular agerelated macular degeneration. e5. 52 Fung AE, Rosenfeld PJ, Reichel E: The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344–1349.